A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Clinical trial NCT03535727 · COMPLETED

Trial details

NCT number: NCT03535727
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Pancreatic Neoplasms Neoplasm, Glandular Neoplasms Neoplasms Pancreatic Digestive System Neoplasm Endocrine Gland Neoplasms Digestive System Disease Pancreatic Diseases Endocrine System Diseases

Start date: 2018-06-21
Primary completion: 2022-10-03
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.